Control of FOX protein activity, localization, and stability depends critically on
post-translational modifications (PTMs). These modifications, including phosphorylation,
methylation and acetylation, help FOX proteins respond to various cellular signals, thereby enabling them to mediate essential biological processes such as
apoptosis, cell survival, and cell cycle progression. Among the primary PTMs influencing FOX proteins is
phosphorylation. For instance, phosphorylation of FOXO
proteins can drive their nuclear translocation in response to stress signals, which is necessary for starting apoptotic
gene expression. This change allows FOXO proteins to mediate the stress reaction and control cell survival. Particularly in relation to the development of
cancer and the way cells traverse their growth cycle,
acetylation is particularly crucial in determining the function of FOXM1. Enzymes such as
p300/CBP add
acetyl groups to specific sites on the FOXM1 protein, thus this process occurs. Particularly, this happens at particular lysine residues, including K63, K422, K440, K603, and K614. FOXM1 is able to greatly increase its capacity to activate genes linked with DNA copying and
cell division by means of acetylation. Remarkably, the degree of acetylation of FOXM1 varies during the cell cycle rather than being constant. It peaks in the S, G2, and M phases of the
cell cycle—the times when cells are actively getting ready for division. During these phases, the acetylated form of FOXM1 can more readily attach to its target genes, helping the cell to move through the cell cycle. On the other hand, FOXM1 becomes less active in the
G1 phase, and the degree of acetylation also falls here. This variation in acetylation serves as a timing mechanism to guarantee that FOXM1 only acts when the cell needs it. Regarding cancer, the stakes are even higher. Acetylation improves FOXM1's capacity to activate genes, helping cancer
cells grow, survive, and repair their DNA. When FOXM1 cannot be acetylated, as is the case when
mutations stop the process from happening, its capacity to activate genes reduces, as well as its capacity to cause the development of tumours. This is why
scientists are looking at several approaches to interfere with FOXM1's acetylation in order to either stop or slow down cancer's spread. The focus of this process could create fresh paths for the evolution of the next treatments. Another post translational modification of the FOX protein involves adding
methyl groups to specific amino acids. These modifications play a crucial role in
immune response, cancer progression, and aging by altering FOX protein functions through protein-level changes. ==Discovery==